|
|
Selection criteria examples
MW, number of rot. bonds, H-bond D&Acc, PSA, pKa, „rule of 25“ ...
exclude „frequent hitters“, reactive or toxic groups, other unwanted features
include general or therapeutic class drug property distributions
information entropy based diversity design
|